AGM/EGMJul 10, 2026, 04:08 PM
Aardvark Therapeutics Proposes Stock Option Repricing at 2026 Annual Meeting
AI Summary
Aardvark Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on August 14, 2026, at 9:00 a.m. Pacific Time. Shareholders as of June 18, 2026, are eligible to vote on proposals including the election of two Class I directors, the ratification of BDO USA, P.C. as the independent auditor for 2026, and the approval of repricing certain outstanding stock options under the 2017, 2025, and 2025 Inducement Equity Incentive Plans. The Board of Directors recommends voting 'FOR' all proposals.
Key Highlights
- Aardvark Therapeutics' 2026 Annual Meeting of Stockholders will be held virtually on August 14, 2026.
- Shareholders will vote on the election of two Class I directors for terms expiring in 2029.
- Proposal to ratify BDO USA, P.C. as the independent auditor for the year ending December 31, 2026.
- Shareholders to approve repricing of certain stock options under the 2017, 2025, and 2025 Inducement Equity Incentive Plans.
- The record date for voting eligibility is June 18, 2026.
- 21,884,158 shares of common stock were outstanding as of the record date.
- The Board of Directors recommends voting 'FOR' all proposals.
Price Impact
More from AARD